Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hayden Locke, CEO Emmerson plc, a low cost high margin potash investment
Richard Slape, Oil consultant - Avoiding Losers and Picking Winners, his personal strategy




Share Price Information for Immupharma (IMM)


Share Price: 11.125Bid: 11.00Ask: 11.25Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 0.25Spread as %: 2.27%Open: 11.90High: 0.00Low: 0.00Yesterday’s Close: 11.125

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
11.125
Share Price SpacerBid
11.00
Share Price SpacerAsk
11.25
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
11.90
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
11.125
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 139.47m £15.52m 20,000

52 Week High 189.00 52 Week High Date 3-APR-2018
52 Week Low 9.06 52 Week Low Date 5-NOV-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -2.342 -4.75 0.00 0.00


London South East Users info for Immupharma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Mar-19
17:07:56
11.125
25,000
 
11.00
11.25
2,781
Trade Type:
Ordinary

22-Mar-19
16:31:49
11.20
52,309
Sell* 
11.00
12.00
5,859
Trade Type:
Ordinary

22-Mar-19
15:45:55
11.40
27,000
Sell* 
11.30
11.80
3,078
Trade Type:
Automatic execution




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>


a-2-b
Posts: 1,222
Opinion:No Opinion
Price:11.125
IMM
Today 13:15
News this week I reckon
bustabloodvesle
Posts: 1,747
Opinion:No Opinion
Price:11.50
Bell end
Fri 14:42
Someone keeps selling around 12p mark
halfbutt
Posts: 133
Opinion:No Opinion
Price:11.95
RE: Incanthera Extension
Fri 10:42
Ask is 12.45..... that's mOving a bit..... on low volume ..wonder where it's going today
dallo
Posts: 535
Premium Chat Member
Opinion:No Opinion
Price:11.95
RE: Line of Duty
Fri 09:48
Apologises
Wrong board
dallo
Posts: 535
Premium Chat Member
Opinion:No Opinion
Price:11.95
Line of Duty
Fri 09:48
I see Line of Duty ( 5th Series) has started again on BBC to universal acclaim.
This award-winning series is made by ITV Studios ( World Production ) for the BBC
and like The Bodyguard again made by ITV for the BBC is a major hit in the USA.
ITV Studios keeps pumping them out but how long before one of the big boys
sees the bargain that is ITV share price at just £1.32p just off 5-year lows.
View more share chat for Immupharma (IMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.